Shares of drug firm Granules India today surged over 6 per cent after the company said it has received Establishment Inspection Report (EIR) from the US health regulator for the OmniChem facility at Vizag, Andhra Pradesh.
The stock soared 6.37 per cent to end at Rs 121.85 on BSE. During the day, it jumped 7.20 per cent to Rs 122.80.
At NSE, shares of the company rose by 6.19 per cent to settle at Rs 121.80.
The company's market valuation went up by Rs 472.16 crore to Rs 3,092.16 crore.
In terms of equity volume, 8.12 lakh shares of the company were traded on BSE and over 98 lakh shares changed hands at NSE during the day.
OmniChem facility is operated by 50:50 joint venture of Granules India and Ajinimoto OmniChem N V, it said in a filing on BSE.
"This facility was inspected by the USFDA in December 2016 and there were seven observations during the inspection. The facility manufactures Active Pharmaceutical Ingredients (API) intermediates," Granules India said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
